Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Fluorescent carbon nanoparticles in cancer diagnostic and therapy systems

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F49777513%3A23640%2F24%3A43975706" target="_blank" >RIV/49777513:23640/24:43975706 - isvavai.cz</a>

  • Výsledek na webu

    <a href="https://www.sciencedirect.com/science/article/abs/pii/B9780443135910000176" target="_blank" >https://www.sciencedirect.com/science/article/abs/pii/B9780443135910000176</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/B978-0-443-13591-0.00017-6" target="_blank" >10.1016/B978-0-443-13591-0.00017-6</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Fluorescent carbon nanoparticles in cancer diagnostic and therapy systems

  • Popis výsledku v původním jazyce

    Fluorescent carbon nanoparticles (FCNPs) have emerged as a promising class of nanomaterials for cancer theranostic, combining diagnostic and therapeutic capabilities into a single platform. These nanoparticles (NPs) possess unique optical properties, including tunable fluorescence emission, excellent photostability, and low cytotoxicity, making them attractive for bioimaging and sensing applications. Additionally, FCNPs can act as nanocarriers for delivering chemotherapeutic drugs, gene therapeutics, or photosensitizers for photodynamic therapy. This typical chapter comprehensively overviews the latest developments using FCNPs for cancer diagnosis and treatment. We discuss the various synthesis methods, surface functionalization strategies, and the mechanisms underlying their fluorescence behavior. The applications of FcnPs in cancer cell imaging, tumor targeting, and drug delivery are highlighted, focusing on their ability to enhance the specificity and efficacy of cancer treatment. Recent advances in developing multifunctional FCNPs for multimodal imaging, combined chemo-photodynamic therapy, and stimuli-responsive drug release have also been explored. Furthermore, the challenges and perspectives associated with the clinical translation of FCNPs-based theranostic systems, including biocompatibility, biodistribution, and clearance considerations were addressed. Overall, this chapter underscores the significant potential of FCNPs as versatile nanoplatforms for integrated cancer diagnosis and therapy, paving the way for personalized and targeted cancer management strategies.

  • Název v anglickém jazyce

    Fluorescent carbon nanoparticles in cancer diagnostic and therapy systems

  • Popis výsledku anglicky

    Fluorescent carbon nanoparticles (FCNPs) have emerged as a promising class of nanomaterials for cancer theranostic, combining diagnostic and therapeutic capabilities into a single platform. These nanoparticles (NPs) possess unique optical properties, including tunable fluorescence emission, excellent photostability, and low cytotoxicity, making them attractive for bioimaging and sensing applications. Additionally, FCNPs can act as nanocarriers for delivering chemotherapeutic drugs, gene therapeutics, or photosensitizers for photodynamic therapy. This typical chapter comprehensively overviews the latest developments using FCNPs for cancer diagnosis and treatment. We discuss the various synthesis methods, surface functionalization strategies, and the mechanisms underlying their fluorescence behavior. The applications of FcnPs in cancer cell imaging, tumor targeting, and drug delivery are highlighted, focusing on their ability to enhance the specificity and efficacy of cancer treatment. Recent advances in developing multifunctional FCNPs for multimodal imaging, combined chemo-photodynamic therapy, and stimuli-responsive drug release have also been explored. Furthermore, the challenges and perspectives associated with the clinical translation of FCNPs-based theranostic systems, including biocompatibility, biodistribution, and clearance considerations were addressed. Overall, this chapter underscores the significant potential of FCNPs as versatile nanoplatforms for integrated cancer diagnosis and therapy, paving the way for personalized and targeted cancer management strategies.

Klasifikace

  • Druh

    C - Kapitola v odborné knize

  • CEP obor

  • OECD FORD obor

    21001 - Nano-materials (production and properties)

Návaznosti výsledku

  • Projekt

  • Návaznosti

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Ostatní

  • Rok uplatnění

    2024

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název knihy nebo sborníku

    Fluorescent Carbon Nanoparticles: Fundamentals and Applications

  • ISBN

    978-0-443-13591-0

  • Počet stran výsledku

    49

  • Strana od-do

    367-415

  • Počet stran knihy

    867

  • Název nakladatele

    Elsevier

  • Místo vydání

    Nizozemí

  • Kód UT WoS kapitoly